Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Human Health Sciences, Kyoto University Graduate School of Medicine, Kyoto, Japan.
JAMA Netw Open. 2024 Jan 2;7(1):e2351518. doi: 10.1001/jamanetworkopen.2023.51518.
The global burden of chronic kidney disease (CKD) is substantial and potentially leads to higher health care resource use.
To examine the association between early-stage CKD and health care spending and its changes over time in the general population.
DESIGN, SETTING, AND PARTICIPANTS: Cohort study using nationwide health checkup and medical claims data in Japan. Participants included individuals aged 30 to 70 years with estimated glomerular filtration rates (eGFR) of 30 mL/min/1.73 m2 or greater at the baseline screening in 2014. Data analyses were conducted from April 2021 to October 2023.
The CKD stages at baseline, defined by the eGFR and proteinuria, were as follows: eGFR of 60 mL/min/1.73 m2 or greater without proteinuria, eGFR of 60 mL/min/1.73 m2 or greater with proteinuria, eGFR of 30 to 59 mL/min/1.73 m2 without proteinuria, and eGFR of 30 to 59 mL/min/1.73 m2 with proteinuria.
The primary outcome was excess health care spending, defined as the absolute difference in health care spending according to the baseline CKD stages (reference group: eGFR ≥60 mL/min/1.73 m2 without proteinuria) in the baseline year (2014) and in the following 5 years (2015 to 2019).
Of the 79 988 participants who underwent a health checkup (mean [SD] age, 47.0 [9.4] years; 22 027 [27.5%] female), 2899 (3.6%) had an eGFR of 60 mL/min/1.73 m2 or greater with proteinuria, 1116 (1.4%) had an eGFR of 30 to 59 mL/min/1.73 m2 without proteinuria, and 253 (0.3%) had an eGFR of 30 to 59 mL/min/1.73 m2 with proteinuria. At baseline, the presence of proteinuria and an eGFR less than 60 mL/min/1.73 m2 were associated with greater excess health care spending (adjusted difference, $178; 99% CI, $6-$350 for proteinuria; $608; 99% CI, $233-$983 for an eGFR of 30-59 mL/min/1.73 m2; and $1254; 99% CI, $134-$2373 for their combination). The study consistently found excess health care spending over the following 5 examined years.
In this cohort study of nationwide health checkup and medical claims data in Japan, early-stage CKD was associated with excess health care spending over the 5 examined years, and the association was more pronounced with a more advanced disease stage.
全球慢性肾脏病(CKD)负担沉重,可能导致更高的医疗保健资源使用。
研究早期 CKD 与医疗保健支出之间的关联及其在普通人群中随时间的变化。
设计、设置和参与者:利用日本全国健康检查和医疗索赔数据进行的队列研究。参与者包括在 2014 年基线筛查时肾小球滤过率(eGFR)为 30 mL/min/1.73 m2 或更高的 30 至 70 岁人群。数据分析于 2021 年 4 月至 2023 年 10 月进行。
根据 eGFR 和蛋白尿,基线时的 CKD 分期如下:eGFR 为 60 mL/min/1.73 m2 或更高且无蛋白尿、eGFR 为 60 mL/min/1.73 m2 或更高且有蛋白尿、eGFR 为 30 至 59 mL/min/1.73 m2 且无蛋白尿和 eGFR 为 30 至 59 mL/min/1.73 m2 且有蛋白尿。
主要结局是过度医疗保健支出,定义为根据基线 CKD 分期(参考组:无蛋白尿时 eGFR≥60 mL/min/1.73 m2)在基线年(2014 年)和随后 5 年(2015 年至 2019 年)之间的绝对差异。
在接受健康检查的 79988 名参与者中(平均[标准差]年龄,47.0[9.4]岁;22027[27.5%]为女性),2899 名(3.6%)有 eGFR 为 60 mL/min/1.73 m2 或更高且有蛋白尿,1116 名(1.4%)有 eGFR 为 30 至 59 mL/min/1.73 m2 且无蛋白尿,253 名(0.3%)有 eGFR 为 30 至 59 mL/min/1.73 m2 且有蛋白尿。在基线时,蛋白尿和 eGFR 低于 60 mL/min/1.73 m2 与更大的过度医疗保健支出相关(调整差异,$178;99%CI,$6-$350 为蛋白尿;$608;99%CI,$233-$983 为 eGFR 为 30-59 mL/min/1.73 m2;$1254;99%CI,$134-$2373 为两者的组合)。研究在随后的 5 年中一致发现过度医疗保健支出。
在这项针对日本全国健康检查和医疗索赔数据的队列研究中,早期 CKD 与随后 5 年的过度医疗保健支出相关,并且与更严重的疾病阶段相关的关联更为明显。